Baxter PE Ratio 2006-2018 | BAX

Current and historical PE ratio for Baxter (BAX) from 2006 to 2018. The price to earnings or PE ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Baxter (BAX) as of March 31, 2018 is 28.74.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.003B $10.561B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $118.977B 18.41
Abbott Laboratories (ABT) United States $111.012B 23.28
Stryker (SYK) United States $65.138B 26.05
Boston Scientific (BSX) United States $46.596B 25.98
Zimmer Biomet Holdings (ZBH) United States $22.697B 14.30
ResMed (RMD) United States $15.606B 32.64
Smith & Nephew SNATS (SNN) United Kingdom $15.513B 0.00
Perrigo (PRGO) Ireland $10.519B 14.75
Bio-Rad Laboratories (BIO) United States $9.103B 73.42
Hill-Rom Holdings (HRC) United States $6.270B 22.52
ICU Medical (ICUI) United States $6.108B 56.83
Canopy Growth (CGC) Canada $5.270B 0.00
Agios Pharmaceuticals (AGIO) United States $5.246B 0.00
Haemonetics (HAE) United States $5.150B 53.04
Insulet (PODD) United States $5.146B 0.00
Hutchison China MediTech (HCM) China $4.495B 0.00
Neogen (NEOG) United States $4.235B 67.72
GW Pharmaceuticals (GWPH) United Kingdom $4.061B 0.00
National Vision Holdings (EYE) United States $3.046B 0.00
NuVasive (NUVA) United States $2.748B 27.78
Quidel (QDEL) United States $2.607B 114.08
Phibro Animal Health (PAHC) United States $1.915B 28.44
Abaxis,Inc (ABAX) United States $1.905B 64.08
NxStage Medical (NXTM) United States $1.838B 0.00
VAREX IMAGING (VREX) United States $1.450B 22.34
Eagle Pharmaceuticals (EGRX) United States $1.237B 34.60
Cardiovascular Systems (CSII) United States $1.178B 0.00
Orthofix (OFIX) $1.126B 34.30
Owens & Minor (OMI) United States $1.078B 10.84
AtriCure (ATRC) United States $1.041B 0.00
OraSure Technologies (OSUR) United States $1.034B 62.70
Cerus (CERS) United States $0.982B 0.00
Omeros (OMER) United States $0.948B 0.00
TG Therapeutics (TGTX) United States $0.948B 0.00
MacroGenics (MGNX) United States $0.940B 0.00
Surmodics (SRDX) United States $0.805B 138.07
LeMaitre Vascular (LMAT) United States $0.709B 41.70
Meridian Bioscience (VIVO) United States $0.671B 23.66
PetIQ (PETQ) United States $0.656B 0.00
Insys Therapeutics (INSY) United States $0.578B 0.00
Lantheus Holdings (LNTH) United States $0.524B 13.70
Evolus (EOLS) United States $0.480B 0.00
Surface Oncology (SURF) United States $0.363B 0.00
Quanterix (QTRX) United States $0.358B 0.00
Cytosorbents (CTSO) United States $0.356B 0.00
Utah Medical Products (UTMD) United States $0.355B 23.52
NanoString Technologies (NSTG) United States $0.314B 0.00
BioLife Solutions (BLFS) United States $0.311B 0.00
Rockwell Medical (RMTI) United States $0.242B 0.00
Chimerix (CMRX) United States $0.220B 0.00
Bovie Medical (BVX) United States $0.172B 0.00
Fonar (FONR) United States $0.172B 10.42
Chembio Diagnostics (CEMI) United States $0.160B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.133B 0.00
Female Health (VERU) United States $0.110B 0.00
Trinity Biotech (TRIB) Ireland $0.104B 31.13
Oramed Pharmaceuticals (ORMP) Israel $0.098B 0.00
United-Guardian (UG) United States $0.087B 20.43
Neurotrope (NTRP) United States $0.079B 0.00
InfuSystems Holdings (INFU) United States $0.073B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Capricor Therapeutics (CAPR) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.035B 0.00
Myomo (MYO) United States $0.031B 0.00
Senestech (SNES) United States $0.027B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00